These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 368879)

  • 21. Activation of the fibrinolytic system.
    Robison AK; Collen D
    Cardiol Clin; 1987 Feb; 5(1):13-9. PubMed ID: 3103919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Molecular mechanisms of thrombolytic therapy].
    Lijnen HR; Collen D
    Haemostasis; 1986; 16 Suppl 4():3-15. PubMed ID: 2945768
    [No Abstract]   [Full Text] [Related]  

  • 23. Age-related differences in a clot lysis assay after adding different plasminogen activators in a plasma milieu in vitro.
    Ries M; Zenker M; Klinge J; Keuper H; Harms D
    J Pediatr Hematol Oncol; 1995 Aug; 17(3):260-4. PubMed ID: 7620925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The search for the ideal thrombolytic agent.
    Verstraete M
    J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):4B-10B. PubMed ID: 2959714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of a sustained fibrinolytic response by BRL 26921 in vitro.
    Fears R; Green J; Smith RA; Walker P
    Thromb Res; 1985 May; 38(3):251-60. PubMed ID: 3895561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The activation mechanism of human plasminogen.
    Rickli EE
    Thromb Diath Haemorrh; 1975 Nov; 34(2):386-95. PubMed ID: 128150
    [No Abstract]   [Full Text] [Related]  

  • 27. Impairment of fibrinolysis by streptokinase, urokinase and recombinant tissue-type plasminogen activator in the presence of radiographic contrast agents.
    Dehmer GJ; Gresalfi N; Daly D; Oberhardt B; Tate DA
    J Am Coll Cardiol; 1995 Apr; 25(5):1069-75. PubMed ID: 7897118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the binding of native plasminogen to fibrin and its role in thrombolysis.
    Shah GA; Dhall DP
    Thromb Res; 1983 Oct; 32(1):67-72. PubMed ID: 6658707
    [No Abstract]   [Full Text] [Related]  

  • 29. The activation of two isozymes of glu-plasminogen (I and II) by urokinase and streptokinase.
    Takada A; Takada Y
    Thromb Res; 1983 Jun; 30(6):633-42. PubMed ID: 6351345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissolution of thrombi by tissue plasminogen activator, urokinase and streptokinase in an artificial circulating system.
    Mattsson C; Nyberg-Arrhenius V; Wallén P
    Thromb Res; 1981 Mar; 21(6):535-45. PubMed ID: 7022741
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on activator formation in human plasma with streptokinase. II. Quantitative activator and plasminogen measurements during continuous and intermittent streptokinase infusion.
    Martin M
    Thromb Diath Haemorrh; 1973 Nov; 30(2):393-402. PubMed ID: 4773378
    [No Abstract]   [Full Text] [Related]  

  • 32. In vitro comparison of fibrinolytic activity of plasminogen activators using a thrombelastographic method: in vivo evaluation of the B-chain-streptokinase complex in the dog model using pre-titered doses.
    Summaria L; Sandesara J; Yang G; Vagher JP; Caprini JA
    Thromb Haemost; 1986 Aug; 56(1):71-9. PubMed ID: 2946093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of fibrinolytic system by liquoid (polyanetholesulfonate). A contributing factor in the liquoid-induced renal cortical necrosis.
    Gilboa N; Ryan TJ; MacColl R
    Haemostasis; 1987; 17(3):162-70. PubMed ID: 3038710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of omega-aminoacids and clot formation on the activation by urokinase of various plasminogen preparations.
    Takada A; Takada Y
    Thromb Res; 1980 Apr 1-15; 18(1-2):167-76. PubMed ID: 6773180
    [No Abstract]   [Full Text] [Related]  

  • 35. Different effect of 5,6-trans-prostaglandin E2 on plasminogen activation by urokinase and streptokinase.
    Urano T; Ikeda C; Shimokawa M; Kinoshita T
    Biochim Biophys Acta; 1994 Apr; 1205(2):258-61. PubMed ID: 8155706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monitoring activity of fibrinolytic agents. A therapeutic challenge.
    Shafer KE; Santoro SA; Sobel BE; Jaffe AS
    Am J Med; 1984 May; 76(5):879-86. PubMed ID: 6232847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The level of extrinsic plasminogen activator (t-PA) during clotting as a determinant of the rate of fibrinolysis; inefficiency of activators added afterwards.
    Brommer EJ
    Thromb Res; 1984 Apr; 34(2):109-15. PubMed ID: 6539513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of streptokinase and urokinase on microarterial thrombosis and haemostasis. An experimental study in rabbits.
    Arnljots B; Dougan P; Salemark L; Bergqvist D
    Scand J Plast Reconstr Surg Hand Surg; 1994 Mar; 28(1):9-13. PubMed ID: 8029659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [On the problem of postmortem fibrinolysis. Activation and inhibition of postmortem fibrinolysis with streptokinase and epsilon-aminocaprioic acid].
    Harms D
    Blut; 1965 Sep; 11(6):345-51. PubMed ID: 5835631
    [No Abstract]   [Full Text] [Related]  

  • 40. [Thrombolytics and their use].
    Alessi MC; Juhan-Vague I
    Rev Prat; 1999 Oct; 49(15):1654-8. PubMed ID: 10581996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.